The Rivkin Center envisions a world where women live longer and healthier lives because cancers are prevented, caught early, or cured. The mission of the Rivkin Center is to improve women’s health by helping them prevent, detect early, and survive ovarian and breast cancer.

Research: Investing in cutting-edge research to prevent, detect and treat ovarian cancer, a deadly and underfunded disease.

Education: Educating women to prevent and detect ovarian and breast cancer as early as possible.

Community: Supporting prevention and early detection screening programs for women at high-risk for ovarian and breast cancers and fostering an ever-growing community of survivors, patients, researchers, clinicians, advocates, and supporters.

The Rivkin Center is a leader in the fight against ovarian cancer with a focus on investing in innovative research to prevent, detect, and treat ovarian cancer, a deadly and underfunded disease and by educating women on the signs, symptoms, and risk factors of the disease. While we have seen progress, ovarian cancer remains the deadliest gynecological cancer, and is the fifth leading cause of women’s cancer deaths in the United States.

We know that when caught in its earliest stages, ovarian cancer survival rates can be as high as 92 percent. Unfortunately, early symptoms of ovarian cancer are difficult to diagnose, and often go undetected until it has spread, which leads to nearly 75% of all ovarian cancer patients being diagnosed in advanced stages. The five-year relative survival rate for all types and stages of ovarian cancer is 47 percent.

Despite these grim statistics, ovarian cancer remains underfunded by national funding agencies. Therefore, the Rivkin Center is focused on funding ovarian cancer research and education and envisions a day when women no longer die of this terrible disease.